Effects of underlying heart failure on outcomes of COVID-19; a systematic review and meta-analysis

Soroush Morsali1, Erfan Rezazadeh-Gavgani1, Mobina Oladghaffari1

  • 1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

Patients with heart failure face higher risks of death and mechanical ventilation when infected with COVID-19. Further research is needed to understand other risks for better preventive care.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Patients with underlying cardiac conditions, particularly heart failure, face elevated risks for severe outcomes from COVID-19 (Coronavirus 2019 disease).
  • This study investigates the specific risks associated with COVID-19 infection in individuals with pre-existing heart failure.

Approach:

  • A systematic literature search was conducted across major databases (PubMed, Scopus, Ovid, ProQuest, Web of Science, Cochrane Library).
  • Meta-analysis of 27 eligible studies involving COVID-19 patients with heart failure was performed using Comprehensive Meta-Analysis (CMA.2) software.

Key Points:

  • Heart failure patients demonstrated a significantly higher susceptibility to mortality (OR: 2.570) and increased need for mechanical ventilation (OR: 1.707) following COVID-19 infection.
  • Investigated outcomes included mortality, hospitalization length, ICU admission, mechanical ventilation, and major cardiovascular conditions.

Conclusions:

  • Pre-existing heart failure is a critical risk factor for increased mortality and mechanical ventilation requirements in COVID-19 patients.
  • Further research is essential to quantify risks for hospitalization, length of stay, readmission, and multiorgan failure to optimize preventive strategies and healthcare planning.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
41
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
26
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
483
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
36